NYSE:RMED Ra Medical Systems - RMED Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ra Medical Systems, Inc Please log in to your account or sign up in order to add this asset to your watchlist. $3.06 +0.04 (+1.32%) (As of 02/2/2023 01:18 PM ET) Add Compare Share Share Today's Range$2.97▼$3.1250-Day Range$2.11▼$6.7852-Week Range$2.03▼$42.00Volume99,546 shsAverage Volume327,636 shsMarket Capitalization$3.34 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Ra Medical Systems (NYSE:RMED) StockRa Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.Read More Receive RMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address RMED Stock News HeadlinesFebruary 1, 2023 | finance.yahoo.comRa Medical Systems Adds Additional Clinical and Sales RepresentativesJanuary 23, 2023 | finance.yahoo.comRa Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association CongressFebruary 2, 2023 | PressReach (Ad)Top AI Tech Stock To WatchToday's stock market news features a Robotics stock with blue sky potential.January 23, 2023 | americanbankingnews.comFinancial Survey: Cerus (NASDAQ:CERS) vs. Ra Medical Systems (NYSE:RMED)January 12, 2023 | forbes.comRa Medical SystemsJanuary 10, 2023 | marketwatch.comRa Medical Systems Shares Drop 10% After Closing Catheter Precision BuyJanuary 10, 2023 | seekingalpha.comRa Medical, Catheter Precision complete merger, plan to raise up to $9.3M in equityJanuary 9, 2023 | finance.yahoo.comRa Medical Systems Completes Merger with Catheter PrecisionFebruary 2, 2023 | PressReach (Ad)Top AI Tech Stock To WatchToday's stock market news features a Robotics stock with blue sky potential.December 14, 2022 | finance.yahoo.comRa Medical Systems Regains Compliance with NYSE American Continued Listing StandardsDecember 3, 2022 | marketwatch.comRa Medical Systems Shares Continue Rise After Thursday DataDecember 1, 2022 | marketwatch.comRa Medical Systems Shares Rise 18% After Usage Data for VIVO Imaging SystemDecember 1, 2022 | finance.yahoo.comCatheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European HospitalsNovember 29, 2022 | finance.yahoo.comCatheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone HospitalNovember 15, 2022 | finance.yahoo.comRa Medical Systems Reports Third Quarter 2022 Financial ResultsOctober 20, 2022 | finance.yahoo.comCatheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation ProceduresOctober 17, 2022 | finance.yahoo.comRa Medical Systems Raises $7.6 Million Through Completed At-The-Market FacilityOctober 4, 2022 | finance.yahoo.comCatheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ TechnologySeptember 29, 2022 | finance.yahoo.comCatheter Precision’s VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual MeetingSeptember 27, 2022 | finance.yahoo.comCatheter Precision Names Fatih Ayoglu as Business Development Manager—EMEASeptember 23, 2022 | benzinga.comSHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and TMX Shareholders About Its Ongoing InvestigationsSeptember 21, 2022 | investorplace.comWhy Was Ra Medical Systems (RMED) Stock Up 20% Today?September 20, 2022 | finance.yahoo.comRa Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock SplitSeptember 19, 2022 | stocknews.com5 Penny Stocks to Sell Before They Hit ZeroSeptember 16, 2022 | benzinga.comSHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and MSTR Shareholders About Its Ongoing InvestigationsSeptember 14, 2022 | benzinga.comShareholder Alert: Ademi LLP investigates whether Ra Medical Systems, Inc.'s transaction with Catheter Precision is fair to shareholdersSeptember 13, 2022 | apnews.comRA MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ra Medical Systems, Inc. - RMEDSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address RMED Company Calendar Last Earnings11/14/2022Today2/02/2023Next Earnings (Estimated)3/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:RMED CUSIPN/A CIK1716621 Webwww.ramed.com Phone(442) 245-4195FaxN/AEmployees58Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($92.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-25,070,000.00 Net Margins-110,533.34% Pretax Margin-142,047.39% Return on Equity-169.55% Return on Assets-119.65% Debt Debt-to-Equity RatioN/A Current Ratio4.83 Quick Ratio4.83 Sales & Book Value Annual Sales$20,000.00 Price / Sales166.77 Cash FlowN/A Price / Cash FlowN/A Book Value$97.53 per share Price / Book0.03Miscellaneous Outstanding Shares1,090,000Free Float1,085,000Market Cap$3.34 million OptionableNot Optionable Beta0.05 Key ExecutivesJonathan Will McGuireChief Executive Officer & DirectorBrian D. ConnChief Financial & Accounting OfficerAlvin MemmoloVP-Clinical, Quality & Regulatory AffairsChristopher FolkVice President-EngineeringMaria Villanueva SessionsVice President & Compliance OfficerKey CompetitorsMotus GINASDAQ:MOTSQuoin PharmaceuticalsNASDAQ:QNRXSintx TechnologiesNASDAQ:SINTInVivo TherapeuticsNASDAQ:NVIVG Medical InnovationsNASDAQ:GMVDView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 116,460 shares on 11/15/2022Ownership: 20.370%Spire Wealth ManagementBought 1,038,267 shares on 11/7/2022Ownership: 95.254%View All Institutional Transactions RMED Stock - Frequently Asked Questions Should I buy or sell Ra Medical Systems stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ra Medical Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMED shares. View RMED analyst ratings or view top-rated stocks. How have RMED shares performed in 2023? Ra Medical Systems' stock was trading at $5.89 at the beginning of the year. Since then, RMED shares have decreased by 48.7% and is now trading at $3.02. View the best growth stocks for 2023 here. When is Ra Medical Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023. View our RMED earnings forecast. How were Ra Medical Systems' earnings last quarter? Ra Medical Systems, Inc (NYSE:RMED) released its quarterly earnings data on Monday, November, 14th. The company reported ($3.86) earnings per share for the quarter. Ra Medical Systems had a negative trailing twelve-month return on equity of 169.55% and a negative net margin of 110,533.34%. When did Ra Medical Systems' stock split? Ra Medical Systems shares reverse split on Monday, October 3rd 2022. The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of Ra Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ra Medical Systems investors own include Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Novan (NOVN), Organigram (OGI), Pennsylvania Real Estate Investment Trust (PEI), CBL & Associates Properties (CBL) and Zosano Pharma (ZSAN). When did Ra Medical Systems IPO? (RMED) raised $50 million in an initial public offering on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers. What is Ra Medical Systems' stock symbol? Ra Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED." How do I buy shares of Ra Medical Systems? Shares of RMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Ra Medical Systems' stock price today? One share of RMED stock can currently be purchased for approximately $3.02. How much money does Ra Medical Systems make? Ra Medical Systems (NYSE:RMED) has a market capitalization of $3.29 million and generates $20,000.00 in revenue each year. The company earns $-25,070,000.00 in net income (profit) each year or ($92.36) on an earnings per share basis. How can I contact Ra Medical Systems? Ra Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The official website for the company is www.ramed.com. The company can be reached via phone at (442) 245-4195 or via email at jcain@lhai.com. This page (NYSE:RMED) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.